Some of my thinking here.
1. Low market cap.
2. Product already developed (Trail result seem expectional)
3. Patents throughout the world
4. Speaking with commercial partners
5. People I know in Healthcare say wound management is one of the most expensive aspects of day to day running of hospital.
Seems like this is just the start of a great deal of announcements
Just some of my thoughts
Good luck to all Holders
DYOR
- Forums
- ASX - By Stock
- TIS
- put this stock away!!
put this stock away!!
Featured News
Add TIS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online